The pandemic provided a reason to the stock market to be excited about the pharma sector that had been facing lacklustre prospects amid challenges in the US business, USFDA compliance issues, pricing pressure, big-bang acquisitions not working out on expected lines and modest growth in the domestic market.
Jane Street may take Singapore route to sort out India tax row
With the Income Tax (I-T) department questioning the tax benefits it had claimed, the Wall Street firm is understood to be working on initiating the
May 25, 2026